David Avigan

This early-phase study is testing whether adding a personalized cancer vaccine can make a powerful cell therapy (CAR-T) work better for people with multiple myeloma that has come back or stopped responding to other treatments. The vaccine is made from a patient's own immune cells…

This is the first-ever study in people to test a new immune cell therapy for acute myeloid leukemia (AML), a serious blood cancer. Researchers will combine a patient's own specially trained immune cells with a vaccine and two standard drugs to see if the approach is safe and can …